Ask the Doctor Discussion Series

We invite multiple myeloma patients and caregivers to this series of informative, virtual discussions

These discussions are designed with patients in mind.  We bring experts in the multiple myeloma field together with patients in an informal atmosphere, where patients and caregivers can get answers to their questions, learn more about multiple myeloma and meet others with the disease. The price for admittance is one question per myeloma patient (but you can ask more!)

Space is limited to 20 multiple myeloma patients and one guest each. This allows time for all attendees to ask questions and be involved in the conversation.

Jing Christine Ye, M.D., M.S. – Friday, April 7, 9:00 a.m.

Associate Professor, Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, Texas. Dr Ye earned her medical degree and master’s degree from Shanghai Jiaotong University School of Medicine in China. She completed her internal medicine residency and hematology oncology fellowship training in Wayne State University. Dr Ye specializes in medical and multidisciplinary management of Plasma Cell Disorders including Multiple Myeloma. Her clinical and research interests have focused on developing innovative therapies and identifying novel biomarkers in myeloma management. She leads/co-leads national cooperative group and industry sponsored clinical trials. Dr Ye serves as the vice chair for NCI SWOG multiple myeloma committee.

Matthew James Pianko, M.D. –Thurs, April 20, 8:30 a.m. The Kensington Hotel, Ann Arbor and via zoom

Dr Pianko’s work is focused on the care of patients with plasma cell disorders and dysproteinemias such as multiple myeloma, smoldering multiple myeloma/asymptomatic multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, light chain (AL) amyloidosis, POEMS syndrome, and monoclonal immunoglobulin/light chain deposition disease (MIDD). Dr. Pianko is interested in clinical research and development of clinical trials of novel drugs and novel drug combinations for patients with these disorders. He will provide an update on treatments, insights into his work and answers to your questions.

Joseph Uberti, M.D., Ph.D.  – Tues, May 2, 11:30 a.m. Venue TBD, Detroit and via Zoom

A specialists in medical hematology and oncology, Dr. Uberti is division chief of Hematology and co-director of the Bone Marrow Transplant Program at the Barbara Ann Karmanos Cancer Institute.  He brings years of experience to the field of transplantation. He is actively involved in clinical research in bone marrow and peripheral blood stem cells transplants and is the expert to answer your questions about transplants as part of a treatment protocol for multiple myeloma patients.

Jeffrey Zonder, M.D. – Wed, May 17, Time TBD, Weisberg Cancer Treatment Center, Farmington Hills and via Zoom

We are extremely excited to be able to offer this meeting during these difficult times. Professor of Oncology at Karmanos Cancer Institute, an MMRC center/Wayne State University School of Medicine, Dr. Zonder has special interest in multidisciplinary care of patients with Multiple Myeloma, as well as other hematologic cancers. In addition, he is focused on the investigation of therapies for Multiple Myeloma.

Craig Emmitt Cole, M.D. – Monday, May 22, Marriott East Lansing at University Place and via Zoom. Time TBD

 Dr. Craig Emmitt Cole, Assistant Professor Division of Hematology and Oncology, Michigan State University College of Human Medicine Karmanos Cancer Institute-McLaren Greater Lansing. Dr. Cole is the Director of Clinical Cancer Research and his research interests include multiple myeloma and smoldering myeloma. A board certified Hematologist who completed his undergraduate degree at Michigan State University and his doctoral degree at The Ohio State University College of Medicine, Dr. Cole had the opportunity to do post-fellowship laboratory research in the Jerome Lipper Multiple Myeloma Center of Medicine at Dana-Farber Cancer Institute/ Harvard Medical School in Boston. His research interest includes multiple myeloma, non-Hodgkin’s lymphoma, therapeutic apheresis, and myelodysplasia.

Jeffrey H. Margolis, M.D. – Wednesday, June 7, 7:00 a.m. Venue TBD, Metro Detroit and via Zoom

Dr. Jeffrey Margolis, Hematologist and Oncologist, President of Michigan Healthcare Professionals, P.C. and Professor of Oncology at Oakland University William Beaumont School of Medicine.

Although the breakfasts are free of charge, you must make reservations to attend.
To save your seat(s) please contact Michele MacWilliams at mmacwilliams@curemultiplemyeloma.org.

You may attend more than one breakfast but space is limited so please provide us with your preferred dates, in order.  We will accommodate as many requests as space permits. We suggest that you come with some questions for the doctor.

Sponsorship packages are available!  Please see additional information here.

It is expensive to run these important events!  If you would like to make a donation, please click below.